2021
DOI: 10.5281/zenodo.5108094
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 and Stock Return: Empirical Evidence from Developing Economy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
1
0
1
Order By: Relevance
“…COVID-19 has impacted profitability (Karim and Shetu, 2023), liquidity, and financial health as well . A large volume of literature has underlined the potential implications of COVID-19 for banks and stock markets based in developed countries (World Economic Forum 2020;Stiller and Zink 2020;Cecchetti and Schoenholtz, 2020;Strietzel et al, 2020) and developing economies (Karim and Saba, 2021). Due to the sudden lockdown from the pandemic, production is stopped, demand for daily necessities has shrunk, and public transportation and movement are restricted locally and internationally (Barua, 2020a, b).…”
Section: Literature Reviewmentioning
confidence: 99%
“…COVID-19 has impacted profitability (Karim and Shetu, 2023), liquidity, and financial health as well . A large volume of literature has underlined the potential implications of COVID-19 for banks and stock markets based in developed countries (World Economic Forum 2020;Stiller and Zink 2020;Cecchetti and Schoenholtz, 2020;Strietzel et al, 2020) and developing economies (Karim and Saba, 2021). Due to the sudden lockdown from the pandemic, production is stopped, demand for daily necessities has shrunk, and public transportation and movement are restricted locally and internationally (Barua, 2020a, b).…”
Section: Literature Reviewmentioning
confidence: 99%
“…Panic buying masyarakat yang disebabkan penerapan kebijakan PSBB, menyebabkan permintaan produksi obat hampir seluruhnya meningkat, termasuk diantaranya antibiotik hingga multivitamin sehingga sektor farmasi memperoleh pertumbuhan yang cukup besar (www.farmasetika.com, 2020). Menurut penelitian (Karim & Saba, 2021) industri farmasi dan kimia menjadi industri yang paling menguntukan. PT Kalbe Farma (KLBF) mencatat pendapatan mengalami peningkatan sebesar Rp 11,605 miliar di kuartal II-2020, atau naik sekitar 3,8 persen dibandingkan Rp 11,179 miliar di periode yang sama tahun 2019 (IDX, 2020).…”
Section: Pendahuluanunclassified